The role of transmembrane segment II in 7TM receptor activation

Current Molecular Pharmacology

Volumn 2, Issue 2, 2009, Pages 140-148

  Benned Jensen, T ^a   Rosenkilde, M M ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

7TM receptors; Constitutive activity; Minor binding pocket; Position II:20; Structure activity relationships

Indexed keywords

CHEMOKINE RECEPTOR; EPSTEIN BARR VIRUS INDUCED RECEPTOR 2; G PROTEIN COUPLED RECEPTOR; GHRELIN RECEPTOR; MELANOCORTIN RECEPTOR; UNCLASSIFIED DRUG; MELANOCORTIN 1 RECEPTOR;

ARTICLE; CRYSTAL STRUCTURE; HUMAN; HYDROGEN BOND; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RECEPTOR INTRINSIC ACTIVITY; STRUCTURE ACTIVITY RELATION; CHEMISTRY; GENETICS; METABOLISM; PHYSIOLOGY; PROTEIN BINDING; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE;

PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, MELANOCORTIN, TYPE 1; RECEPTORS, G-PROTEIN-COUPLED; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 77449147872     PISSN: 18744672     EISSN: 18744702     Source Type: Journal    
DOI: 10.2174/1874467210902020140     Document Type: Article

References (71)

1. Baldwin, J. M. The probable arrangement of the helicee in G protein-coupled receptors. EMBO J. 1993, 12, 1693-703.
2. Schwartz, T. W. Locating ligand-binding sites in 7TM receptors by protein engineering. Curr. Opin. Biotechnol. 1994, 5, 434-444.
3. Ballesteros, J. A.; Weinstein, H. Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors. Methods Neurosci. 1995, 366-428.
4. Dixon, R. A.; Sigal, I. S.; Strader, C. D. Structure-function analysis of the beta-adrenergic receptor. Cold Spring Harb. Symp. Quant. Biol. 1988, 53(Pt 1), 487-497.
5. Strader, C. D.; Sigal, I. S.; Dixon, R. A. Genetic approaches to the determination of structure-function relationships of G protein- coupled receptors. Trends Pharmacol. Sci., 1989, (Suppl), 26-30.
6. Strader, C. D.; Gaffney, T.; Sugg, E. E.; Candelore, M. R.; Keys, R.; Patchett, A. A.; Dixon, R. A. Allele-specific activation of genetically engineered receptors. J. Biol. Chem. 1991, 266, 5-8.
7. Hemmerich, S.; Paavola, C.; Bloom, A.; Bhakta, S.; Freedman, R.; Grunberger, D.; Krstenansky, J.; Lee, S.; McCarley, D.; Mulkins, M.; Wong, B.; Pease, J.; Mizoue, L.; Mirzadegan, T.; Polsky, I.; Thompson, K.; Handel, T. M.; Jarnagin, K. Identification of residues in the monocyte chemotactic protein-1 that contact the MCP-1 receptor, CCR2. Biochemistry 1999, 38, 13013-13025.
8. Jarnagin, K.; Grunberger, D.; Mulkins, M.; Wong, B.; Hemmerich, S.; Paavola, C.; Bloom, A.; Bhakta, S.; Diehl, F.; Freedman, R.; McCarley, D.; Polsky, I.; Ping-Tsou, A.; Kosaka, A.; Handel, T. M. Identification of surface residues of the monocyte chemotactic protein 1 that affect signaling through the receptor CCR2. Biochemistry 1999, 38, 16167-16177.
9. Rosenkilde, M. M.; Gerlach, L. O.; Jakobsen, J. S.; Skerlj, R. T.; Bridger, G. J.; Schwartz, T. W. Molecular mechanism of AMD3100 antagonism in the CXCR4 receptor: transfer of binding site to the CXCR3 receptor. J. Biol. Chem. 2004, 279, 3033-3041.
10. Jensen, P. C.; Thiele, S.; Ulven, T.; Schwartz, T. W.; Rosenkilde, M. M. Positive versus negative modulation of different endogenous chemokines for CC-chemokine receptor 1 by small molecule agonists through allosteric versus orthosteric binding. J. Biol. Chem. 2008, 283, 23121-23128.
11. Rosenkilde, M. M.; Schwartz, T. W. GluVII:06 - A Highly Conserved and Selective Anchor Point for Non-Peptide Ligands in Chemokine Receptors. Curr. Top. Med. Chem. 2006, 6, 1319-1333.
12. Mirzadegan, T.; Benko, G.; Filipek, S.; Palczewski, K. Sequence analyses of G-protein-coupled receptors: similarities to rhodopsin. Biochemistry 2003, 42, 2759-2767.
13. Elling, C. E.; Frimurer, T. M.; Gerlach, L. O.; Jorgensen, R.; Holst, B.; Schwartz, T. W. Metal ion site engineering indicates a global toggle switch model for seven-transmembrane receptor activation. J. Biol. Chem. 2006, 281, 17337-17346.
14. Schwartz, T. W.; Frimurer, T. M.; Holst, B.; Rosenkilde, M. M.; Elling, C. E. Molecular mechanism of 7TM receptor activation--a global toggle switch model. Annu. Rev. Pharmacol. Toxicol. 2006, 46, 481-519.
15. Shi, L.; Liapakis, G.; Xu, R.; Guarnieri, F.; Ballesteros, J. A.; Javitch, J. A. Beta2 adrenergic receptor activation. Modulation of the proline kink in transmembrane 6 by a rotamer toggle switch. J. Biol. Chem. 2002, 277, 40989-40996.
16. McAllister, S. D.; Hurst, D. P.; Barnett-Norris, J.; Lynch, D.; Reggio, P. H.; Abood, M. E. Structural mimicry in class A G protein-coupled receptor rotamer toggle switches: the importance of the F3.36(201)/W6.48(357) interaction in cannabinoid CB1 receptor activation. J. Biol. Chem. 2004, 279, 48024-48037.
17. Hubbell, W. L.; Altenbach, C.; Hubbell, C. M.; Khorana, H. G. Rhodopsin structure, dynamics, and activation: a perspective from crystallography, site-directed spin labeling, sulfhydryl reactivity, and disulfide cross-linking. Adv. Protein Chem. 2003, 63, 243-290.
18. Rosenkilde, M. M.; Andersen, M. B.; Nygaard, R.; Frimurer, T. M.; Schwartz, T. W. Activation of the CXCR3 chemokine receptor through anchoring of a small molecule chelator ligand between TM-III, -IV, and -VI. Mol. Pharmacol. 2007, 71, 930-941.
19. Altenbach, C.; Kusnetzow, A. K.; Ernst, O. P.; Hofmann, K. P.; Hubbell, W. L. High-resolution distance mapping in rhodopsin reveals the pattern of helix movement due to activation. Proc. Natl. Acad. Sci. USA 2008, 105, 7439-7444.
20. Park, J. H.; Scheerer, P.; Hofmann, K. P.; Choe, H. W.; Ernst, O. P. Crystal structure of the ligand-free G-protein-coupled receptor opsin. Nature 2008, 454(7201), 183-187.
21. Scheerer, P.; Park, J. H.; Hildebrand, P. W.; Kim, Y. J.; Krauss, N.; Choe, H. W.; Hofmann, K. P.; Ernst, O. P. Crystal structure of opsin in its G-protein-interacting conformation. Nature 2008, 455, 497-502.
22. Palczewski, K.; Kumasaka, T.; Hori, T.; Behnke, C. A.; Motoshima, H.; Fox, B. A.; Le Trong, I.; Teller, D. C.; Okada, T.; Stenkamp, R. E.; Yamamoto, M.; Miyano, M. Crystal structure of rhodopsin: A G protein-coupled receptor. Science 2000, 289, 739-745.
23. Perlman, J. H.; Colson, A. O.; Wang, W.; Bence, K.; Osman, R.; Gershengorn, M. C. Interactions between conserved residues in transmembrane helices 1, 2, and 7 of the thyrotropin-releasing hormone receptor. J. Biol. Chem. 1997, 272, 11937-11942.
24. Dragic, T.; Trkola, A.; Thompson, D. A.; Cormier, E. G.; Kajumo, F. A.; Maxwell, E.; Lin, S. W.; Ying, W.; Smith, S. O.; Sakmar, T. P.; Moore, J. P. A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5. Proc. Natl. Acad. Sci. USA 2000, 97, 5639-5644.
25. Neve, K. A.; Cumbay, M. G.; Thompson, K. R.; Yang, R.; Buck, D. C.; Watts, V. J.; DuRand, C. J.; Teeter, M. M. Modeling and mutational analysis of a putative sodium-binding pocket on the dopamine D2 receptor. Mol. Pharmacol. 2001, 60, 373-381.
26. Scheer, A.; Fanelli, F.; Costa, T.; Cotecchia, S. Constitutively active mutants of the alpha1B-adrenergic receptor: role of highly conserved polar amino acids in receptor activation. EMBO J. 1996, 15, 3566-3578.
27. Ballesteros, J.; Kitanovic, S.; Guarnieri, F.; Davies, P.; Fromme, B. J.; Konvicka, K.; Chi, L.; Millar, R. P.; Davidson, J. S.; Weinstein, H.; Sealfon, S. C. Functional microdomains in G-protein-coupled receptors. The conserved arginine-cage motif in the gonadotropin- releasing hormone receptor. J. Biol. Chem. 1998, 273, 10445-10453.
28. Urizar, E.; Claeysen, S.; Deupi, X.; Govaerts, C.; Costagliola, S.; Vassart, G.; Pardo, L. An activation switch in the rhodopsin family of G protein-coupled receptors: the thyrotropin receptor. J. Biol. Chem. 2005, 280, 17135-17141.
29. Zhou, W.; Flanagan, C.; Ballesteros, J. A.; Konvicka, K.; Davidson, J. S.; Weinstein, H.; Millar, R. P.; Sealfon, S. C. A reciprocal mutation supports helix 2 and helix 7 proximity in the gonadotropin-releasing hormone receptor. Mol. Pharmacol. 1994, 45, 165-170.
30. Cohen, G. B.; Oprian, D. D.; Robinson, P. R. Mechanism of activation and inactivation of opsin: role of Glu113 and Lys296. Biochemistry 1992, 31, 12592-12601.
31. Cohen, G. B.; Yang, T.; Robinson, P. R.; Oprian, D. D. Constitutive activation of opsin: influence of charge at position 134 and size at position 296. Biochemistry 1993, 32, 6111-6115.
32. Kim, J. M.; Altenbach, C.; Kono, M.; Oprian, D. D.; Hubbell, W. L.; Khorana, H. G. Structural origins of constitutive activation in rhodopsin: Role of the K296/E113 salt bridge. Proc. Natl. Acad. Sci. USA 2004, 101, 12508-12513.
33. Rosenbaum, D. M.; Cherezov, V.; Hanson, M. A.; Rasmussen, S. G.; Thian, F. S.; Kobilka, T. S.; Choi, H. J.; Yao, X. J.; Weis, W. I.; Stevens, R. C.; Kobilka, B. K. GPCR engineering yields high- resolution structural insights into beta2-adrenergic receptor function. Science 2007, 318, 1266-1273.
34. Rezmann-Vitti, L. A.; Louis, S. N.; Nero, T. L.; Jackman, G. P.; Iakovidis, D.; Machida, C. A.; Louis, W. J. Agonist binding and activation of the rat beta(1)-adrenergic receptor: role of Trp(134(3.28)), Ser(190(4.57)) and Tyr(356(7.43)). Biochem. Pharmacol. 2004, 68, 675-688.
35. Simpson, M. M.; Ballesteros, J. A.; Chiappa, V.; Chen, J.; Suehiro, M.; Hartman, D. S.; Godel, T.; Snyder, L. A.; Sakmar, T. P.; Javitch, J. A. Dopamine D4/D2 receptor selectivity is determined by A divergent aromatic microdomain contained within the second, third, and seventh membrane-spanning segments. Mol. Pharmacol. 1999, 56, 1116-1126.
36. Javitch, J. A.; Ballesteros, J. A.; Chen, J.; Chiappa, V.; Simpson, M. M. Electrostatic and aromatic microdomains within the binding- site crevice of the D2 receptor: contributions of the second membrane-spanning segment. Biochemistry 1999, 38, 7961-7968.
37. Holst, B.; Lang, M.; Brandt, E.; Bach, A.; Howard, A.; Frimurer, T. M.; Beck-Sickinger, A.; Schwartz, T. W. Ghrelin receptor inverse agonists: identification of an active peptide core and its interaction epitopes on the receptor. Mol. Pharmacol. 2006, 70, 936-946.
38. Holst, B.; Mokrosinski, J.; Lang, M.; Brandt, E.; Nygaard, R.; Frimurer, T. M.; Beck-Sickinger, A. G.; Schwartz, T. W. Identification of an efficacy switch region in the ghrelin receptor responsible for interchange between agonism and inverse agonism. J. Biol. Chem. 2007, 282, 15799-15811.
39. Holst, B.; Elling, C. E.; Schwartz, T. W. Metal ion-mediated agonism and agonist enhancement in melanocortin MC1 and MC4 receptors. J. Biol. Chem. 2002, 277, 47662-47670.
40. Haskell-Luevano, C.; Cone, R. D.; Monck, E. K.; Wan, Y. P. Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants. Biochemistry 2001, 40, 6164-6179.
41. Lagerstrom, M. C.; Klovins, J.; Fredriksson, R.; Fridmanis, D.; Haitina, T.; Ling, M. K.; Berglund, M. M.; Schioth, H. B. High affinity agonistic metal ion binding sites within the melanocortin 4 receptor illustrate conformational change of transmembrane region 3. J. Biol. Chem. 2003, 278, 51521-51526.
42. Ling, M. K.; Lagerstrom, M. C.; Fredriksson, R.; Okimoto, R.; Mundy, N. I.; Takeuchi, S.; Schioth, H. B. Association of feather colour with constitutively active melanocortin 1 receptors in chicken. Eur. J. Biochem. 2003, 270, 1441-1449.
43. Sanchez, M. J.; Olivares, S. C.; Ghanem, G.; Haycock, J.; Lozano Teruel, J. A.; Garcia-Borron, J. C.; Jimenez-Cervantes, C. Loss-of- function variants of the human melanocortin-1 receptor gene in melanoma cells define structural determinants of receptor function. Eur. J. Biochem. 2002, 269, 6133-6141.
44. Lu, D.; Vage, D. I.; Cone, R. D. A ligand-mimetic model for constitutive activation of the melanocortin-1 receptor. Mol. Endocrinol. 1998, 12, 592-604.
45. Srinivasan, S.; Santiago, P.; Lubrano, C.; Vaisse, C.; Conklin, B. R. Engineering the melanocortin-4 receptor to control constitutive and ligand-mediated G(S) signaling in vivo. PLoS. ONE 2007, 2, e668.
46. Yang, Y.; Dickinson, C.; Haskell-Luevano, C.; Gantz, I. Molecular basis for the interaction of [Nle4,D-Phe7] melanocyte stimulating hormone with the human melanocortin-1 receptor. J. Biol. Chem. 1997, 272, 23000-23010.
47. Robbins, L. S.; Nadeau, J. H.; Johnson, K. R.; Kelly, M. A.; Roselli-Rehfuss, L.; Baack, E.; Mountjoy, K. G.; Cone, R. D. Pigmentation Phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell 1993, 72, 1-20.
48. Srinivasan, S.; Vaisse, C.; Conklin, B. R. Engineering the melanocortin-4 receptor to control G(s) signaling in vivo. Ann. N. Y. Acad. Sci. 2003, 994, 225-32.
49. Yang, Y. K.; Fong, T. M.; Dickinson, C. J.; Mao, C.; Li, J. Y.; Tota, M. R.; Mosley, R.; Van Der Ploeg, L. H.; Gantz, I. Molecular determinants of ligand binding to the human melanocortin-4 receptor. Biochemistry 2000, 39, 14900-14911.
50. Chen, M.; Cai, M.; Aprahamian, C. J.; Georgeson, K. E.; Hruby, V.; Harmon, C. M.; Yang, Y. Contribution of the conserved amino acids of the melanocortin-4 receptor in [corrected] [Nle4,D-Phe7] - alpha-melanocyte-stimulating [corrected] hormone binding and signaling. J. Biol. Chem. 2007, 282, 21712-21719.
51. Theron, E.; Hawkins, K.; Bermingham, E.; Ricklefs, R. E.; Mundy, N. I. The molecular basis of an avian plumage polymorphism in the wild: a melanocortin-1-receptor point mutation is perfectly associated with the melanic plumage morph of the bananaquit, Coereba flaveola. Curr. Biol. 2001, 11, 550-557.
52. Vage, D. I.; Lu, D.; Klungland, H.; Lien, S.; Adalsteinsson, S.; Cone, R. D. A non-epistatic interaction of agouti and extension in the fox, Vulpes vulpes. Nat. Genet. 1997, 15, 311-315.
53. Birkenbach, M.; Josefsen, K.; Yalamanchili, R.; Lenoir, G.; Kieff, E. Epstein-Barr virus-induced genes: First lymphocyte-specific G protein-coupled peptide receptors. J. Virol. 1993, 67, 2209-2220.
54. Cahir-McFarland, E. D.; Carter, K.; Rosenwald, A.; Giltnane, J. M.; Henrickson, S. E.; Staudt, L. M.; Kieff, E. Role of NF-kappa B in cell survival and transcription of latent membrane protein 1- expressing or Epstein-Barr virus latency III-infected cells. J. Virol. 2004, 78, 4108-4119.
55. Rosenkilde, M. M.; Benned-Jensen, T.; Andersen, H.; Holst, P. J.; Kledal, T. N.; Luttichau, H. R.; Larsen, J. K.; Christensen, J. P.; Schwartz, T. W. Molecular pharmacological phenotyping of EBI2. An orphan seven-transmembrane receptor with constitutive activity. J. Biol. Chem. 2006, 281, 13199-13208.
56. Benned-Jensen, T.; Rosenkilde, M. M. Structural motifs of importance for the constitutive activity of the orphan 7TM receptor EBI2 - Analysis of receptor activation in the absence of an agonist. Mol. Pharmacol. 2008, 74, 1008-21.
57. Hase, M.; Yokomizo, T.; Shimizu, T.; Nakamura, M. Characteriza- tion of an orphan G protein-coupled receptor, GPR20, that constitutively activates Gi proteins. J. Biol. Chem. 2008, 283, 12747-12755.
58. Ge, H.; Weiszmann, J.; Reagan, J. D.; Gupte, J.; Baribault, H.; Gyuris, T.; Chen, J. L.; Tian, H.; Li, Y. Elucidation of signaling and functional activities of an orphan GPCR, GPR81. J. Lipid Res. 2008, 49, 797-803.
59. Briscoe, C. P.; Tadayyon, M.; Andrews, J. L.; Benson, W. G.; Chambers, J. K.; Eilert, M. M.; Ellis, C.; Elshourbagy, N. A.; Goetz, A. S.; Minnick, D. T.; Murdock, P. R.; Sauls, H. R., Jr.; Shabon, U.; Spinage, L. D.; Strum, J. C.; Szekeres, P. G.; Tan, K. B.; Way, J. M.; Ignar, D. M.; Wilson, S.; Muir, A. I. The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. J. Biol. Chem. 2003, 278, 11303-11311.
60. Arias, D. A.; Navenot, J. M.; Zhang, W. B.; Broach, J.; Peiper, S. C. Constitutive activation of CCR5 and CCR2 induced by conformational changes in the conserved TXP motif in transmembrane helix 2. J. Biol. Chem. 2003, 278, 36513-36521.
61. Jiang, Y.; Lee, A.; Chen, J.; Ruta, V.; Cadene, M.; Chait, B. T.; Mackinnon, R. X-ray structure of a voltage-dependent K+ channel. Nature 2003, 423, 33-41.
62. Jiang, Y.; Ruta, V.; Chen, J.; Lee, A.; Mackinnon, R. The principle of gating charge movement in a voltage-dependent K+ channel. Nature 2003, 423, 42-48.
63. Lee, S. Y.; Lee, A.; Chen, J.; Mackinnon, R. Structure of the KvAP voltage-dependent K+ channel and its dependence on the lipid membrane. Proc. Natl. Acad. Sci. USA 2005, 102, 15441-15446.
64. Xu, Y.; Ramu, Y.; Lu, Z. Removal of phospho-head groups of membrane lipids immobilizes voltage sensors of K+ channels. Nature 2008, 451, 826-829.
65. Freites, J. A.; Tobias, D. J.; von, H. G.; White, S. H. Interface connections of a transmembrane voltage sensor. Proc. Natl. Acad. Sci. USA 2005, 102, 15059-15064.
66. Schmidt, D.; Jiang, Q. X.; Mackinnon, R. Phospholipids and the origin of cationic gating charges in voltage sensors. Nature 2006, 444, 775-779.
67. Govaerts, C.; Bondue, A.; Springael, J. Y.; Olivella, M.; Deupi, X.; Le, P. E.; Wodak, S. J.; Parmentier, M.; Pardo, L.; Blanpain, C. Activation of CCR5 by chemokines involves an aromatic cluster between transmembrane helices 2 and 3. J. Biol. Chem. 2003, 278, 1892-1903.
68. Miura, S.; Karnik, S. S. Constitutive activation of angiotensin II type 1 receptor alters the orientation of transmembrane Helix-2. J. Biol. Chem. 2002, 277, 24299-24305.
69. Miura, S.; Zhang, J.; Boros, J.; Karnik, S. S. TM2-TM7 interaction in coupling movement of transmembrane helices to activation of the angiotensin II type-1 receptor. J. Biol. Chem. 2003, 278, 3720-3725.
70. Rosenkilde, M. M.; Cahir, M.; Gether, U.; Hjorth, S. A.; Schwartz, T. W. Mutations along transmembrane segment II of the NK-1 receptor affect substance P competition with non-peptide antagonists but not substance P binding. J. Biol. Chem. 1994, 269, 28160-28164.
71. Maeda, K.; Das, D.; Ogata-Aoki, H.; Nakata, H.; Miyakawa, T.; Tojo, Y.; Norman, R.; Takaoka, Y.; Ding, J.; Arnold, G. F.; Arnold, E.; Mitsuya, H. Structural and molecular interactions of CCR5 inhibitors with CCR5. J. Biol. Chem. 2006, 281, 12688-12698.